Free Trial

Viracta Therapeutics (VIRX) SEC Filings & 10K Form

Viracta Therapeutics logo
$0.19
-0.01 (-4.89%)
(As of 11/1/2024 ET)

Recent Viracta Therapeutics SEC Filings

DateFilerForm TypeView
09/12/2024
5:10 PM
Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
5:13 PM
ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:15 AM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
6:47 PM
Murphy Samuel Lafayette (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:48 PM
Chung Jane (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:49 PM
Borellini Flavia (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:50 PM
ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:39 PM
Rubino Stephen (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:40 PM
Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:43 PM
Barlow Jane F (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:44 PM
Simon Barry J. (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:46 PM
DARCY THOMAS E (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:46 PM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
6:07 PM
ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:12 PM
Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:04 PM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
3:15 PM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form ARS
04/09/2024
3:30 PM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
3:42 PM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
7:29 PM
Chevallard Daniel R. (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
7:33 PM
Cohen Darrel P. (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
7:36 PM
Rothera Mark (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
4:04 PM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2024
7:40 PM
Chevallard Daniel R. (Reporting)
Viracta Therapeutics, Inc. (Subject)
Viracta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2024
6:56 PM
Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:58 PM
ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:54 PM
Chevallard Daniel R. (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
8:04 PM
FORWARD VENTURES V LP (Filed by)
Viracta Therapeutics, Inc. (Subject)
Viracta Therapeutics (Subject)
Form SC 13G
11/28/2023
6:01 PM
Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2023
6:03 PM
ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2023
6:06 PM
Chevallard Daniel R. (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
4:30 PM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
7:30 AM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VIRX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners